No Picture
News

Denovo Biopharma Acquires a Novel Late-Stage Oncology Drug and Expands into Protein Therapeutics

SAN DIEGO, Dec. 10, 2020 /PRNewswire/ — Denovo Biopharma, a pioneer in applying precision medicine to develop innovative therapies, today announced it has licensed its seventh late-stage drug asset: endostatin (now named DB108) from Jiangsu Wuzhong… […]

No Picture
News

Velocity Clinical Research acquires eStudySite Inc to increase volunteer recruitment from Hispanic communities in San Diego

DURHAM, North Carolina, Nov. 11, 2020 /PRNewswire/ — North Carolina-based clinical research site company, Velocity Clinical Research, today announces the acquisition of eStudySite Inc, adding two sites in San Diego, California to its North American… […]

No Picture
News

Bridgewest Australia Holdings LLC Acquires Pfizer manufacturing facility in Adelaide, Australia

Bridgewest to develop the site into a full-service Contract Development and Manufacturing Organization

SAN DIEGO and ADELAIDE, Australia, Sept. 1, 2020 /PRNewswire/ — The Bridgewest Group, a premier private investment company that focuses on disrupt… […]

No Picture
News

Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market

– DelMar Pharmaceuticals, Inc. Name Change to Kintara Therapeutics, Inc.- Kintara Therapeutics to Trade on Nasdaq Capital Market under the Ticker Symbol “KTRA”

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharm… […]

No Picture
News

Heritage Global Partners and Federal Equipment Company to Conduct Major Auction of Veterinary Biologics/Vaccine Manufacturing Site Online Auction Features State of the Art Processing and Lab Equipment

August 19, 2020 – August 20, 2020https://www.hgpauction.com/auctions/104084/vos/
SAN DIEGO, CALIF., July 28, 2020 /PRNewswire/ – Heritage Global Partners (“HGP”), a worldwide leader in asset advisory and auction services, in conjunction with Fede… […]

No Picture
News

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics

— The combination of SmartPharm’s Gene Mab(TM) gene-encoded in vivo expression system and Sorrento’s SARS-CoV-2 neutralizing antibodies may potentially provide longer-acting, single injection protection against COVID-19.– The combination of Sorrento’… […]

No Picture
News

Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Starting With Neutralizing Antibodies To Treat COVID-19 and Cancer Therapeutics

— The combination of SmartPharm’s Gene Mab(TM) gene-encoded in vivo expression system and Sorrento’s SARS-CoV-2 neutralizing antibodies may potentially provide longer-acting, single injection protection against COVID-19.– The combination of Sorrento’… […]